CryoPort Inc (CYRX) – Strategy, SWOT and Corporate Finance Report

CryoPort Inc (CYRX) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Cryoport, Inc. (Cryoport) is a provider of temperature-controlled supply chain solutions. The company manages its shipments through Cryoportal, a cloud-based logistics management platform. It also provides various services which include cryogenic logistics solutions, lab moves solutions, cold chain logistics accessories and consulting solutions; and edge logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cell for clients. The company offers its services to the biopharmaceuticals, labs, diagnostics, clinical trials, clinics and research facilities; animal health, and reproductive medicines. Its key brands include Cryoport Systems, IntegriCell, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. Cryoport is headquartered in the Irvine, California, the US.

Scope

• Detailed information on CryoPort Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting CryoPort Inc in the form of a SWOT analysis

• An in-depth view of the business model of CryoPort Inc including a breakdown and examination of key business segments

• News about CryoPort Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of CryoPort Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess CryoPort Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on CryoPort Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

KK Integrated Logistics

Echo Global Logistics Inc

Hub Group Inc

LifeScience Logistics LLC

Kem Krest Corp

Echo Global Logistics Inc

Hub Group Inc

Kem Krest Corp

KK Integrated Logistics

LifeScience Logistics LLC

Gateway Logistics Group Inc

Marken Ltd

Marken Ltd

Gateway Logistics Group Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

CryoPort Inc - Key Facts

CryoPort Inc - Key Employees

CryoPort Inc - Key Employee Biographies

CryoPort Inc - Major Products and Services

CryoPort Inc - History

CryoPort Inc - Company Statement

CryoPort Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

CryoPort Inc - Business Description

Other Break-up: Animal Health

Overview

Performance

Other Break-up: Human Reproductive Medicine

Overview

Performance

Other Break-up: Pharma/Biopharmaceutical

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Europe, the Middle East and Africa

Performance

R&D Overview

CryoPort Inc - SWOT Analysis

SWOT Analysis - Overview

CryoPort Inc - Strengths

CryoPort Inc - Weaknesses

CryoPort Inc - Opportunities

CryoPort Inc - Threats

CryoPort Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

CryoPort Inc, Recent Deals Summary

Section 4 – Company’s Recent Developments

Mar 28, 2023: Cryoport announces multi-Year agreement with inception fertility

Mar 13, 2023: Cryoport confirms no financial exposure to Silicon Valley Bank

Feb 23, 2023: Cryoport Reports Fourth Quarter and Full Year 2022 Results

Jan 18, 2023: Cryoport announces new strategic partnership with Syneos Health to advance cell & gene therapies

Nov 03, 2022: Cryoport Reports Results for the Third Quarter 2022

Sep 08, 2022: Cryoport enters into strategic relationship with Takeda's BioLife plasma services

Aug 04, 2022: Cryoport Reports Results for the Second Quarter 2022

May 05, 2022: Cryoport Reports First Quarter 2022 Results

Feb 24, 2022: Cryoport Reports Fourth Quarter and Full Year 2021 Results

Feb 09, 2022: Cryoport provides positive update on MVE Biological Solution's new prague facility

Section 5 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

CryoPort Inc, Key Facts

CryoPort Inc, Key Employees

CryoPort Inc, Key Employee Biographies

CryoPort Inc, Major Products and Services

CryoPort Inc, History

CryoPort Inc, Other Locations

CryoPort Inc, Subsidiaries

CryoPort Inc, Key Competitors

CryoPort Inc, Ratios based on current share price

CryoPort Inc, Annual Ratios

CryoPort Inc, Annual Ratios (Cont…1)

CryoPort Inc, Annual Ratios (Cont…2)

CryoPort Inc, Interim Ratios

CryoPort Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

CryoPort Inc, Performance Chart (2018 – 2022)

CryoPort Inc, Ratio Charts

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports